World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

VANCOMYCIN INDUCED RED MAN SYNDROME IN ELDERLY MAN: A CASE REPORT

Sai Charitha Sreeram*, V. Bhavya, P. Lakshmi and D. Ranganayakulu

ABSTRACT

Vancomycin is a glycopeptide antibiotic active against gram positive bacterial infections. It is commonly used to treat Methicillin Resistant Staphylococcus Aureus (MRSA) infections. Most important adverse reaction with vancomycin is hypersensitivity reaction. It is of two types, one is anaphylaxis and other Red Man syndrome (RMS). RMS is also known as “red neck syndrome. It is more common with rapid infusion of Vancomycin. RMS is usually presents with pruritus, erythematous rash commonly involving head, neck and upper part of body and less frequently with chest pain, hypotension and cardiovascular collapse. Discontinuation of antibiotic and treatment with antihistaminic can abort most of the reactions. Slow intravenous administration of vancomycin should minimize the risk of infusion-related adverse effects. This case concerns an elderly man who developed a 'Red Man Syndrome' reaction whilst on intravenous vancomycin therapy for Chronic rheumatic heart disease (CRHD).

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR